The University of Southampton
University of Southampton Institutional Repository

Mediators of airway remodelling in asthma

Mediators of airway remodelling in asthma
Mediators of airway remodelling in asthma

The asthmatic airway demonstrates structural changes termed airway remodelling which include subepithelial collagen deposition and an increase in numbers of myofibroblasts in the mucosa. These changes may contribute to bronchial hyperresponsiveness and to decline in lung function in asthma.

The hypothesis was proposed that proteases, and in particular the plasminogen activating system, may mediate airway remodelling through the release of growth factors such as basic fibroblast growth factor (bFGF) and transforming growth factor-beta (TGF-β) from their binding to the extracellular matrix. The ability of bronchoalveolar lavage fluid (BALF) from asthmatic and non asthmatic subjects to stimulate proliferation in vitro of a transformed human fetal lung fibroblast cell line, MRC-5, was studied by measuring 3H-thymidine uptake.

Use of blocking antibodies and antiproteases demonstrated significant inhibition of BALF-induced fibroblast DNA synthesis (BIDS) by anti-bFGF, by a protease inhibitor cocktail and by the specific plasmin inhibitor, α2-antiplasmin. Plasmin concentrations of BALF correlated with BIDS. Plasmin was shown to stimulate marked proliferation of fibroblasts, an effect that was profoundly inhibited by anti-bFGF. Measurement of cell supernatant concentrations demonstrated rapid release of bFGF from fibroblasts exposed to plasmin. Immunofluorescent confocal microscopy demonstrated plasmin-induced loss of bFGF staining from fibroblasts in vitro. These observations suggest that plasmin is an important fibroproliferative agent in BALF mediating its activity through autocrine release of bFGF.

BIDS within an asthmatic group correlated significantly with bronchial hyperresponsiveness and BALF from steroid-naïve asthmatic subjects with marked bronchial hyperresponsiveness stimulated significantly greater BIDS than that from non-asthmatic subjects. BIDS also correlated with plasmin, bFGF and TGF-β levels in the BALF. Six weeks treatment with inhaled budesonide, nedocromil or placebo led to significant reductions in BIDS and plasmin concentrations only in the inhaled corticosteroid group and bFGF concentrations fell following treatment with budesonide, a change that was significantly different from that due to placebo.

University of Southampton
McConnell, William David
0d19994f-50bc-486d-b06a-8639f2d2193a
McConnell, William David
0d19994f-50bc-486d-b06a-8639f2d2193a

McConnell, William David (2003) Mediators of airway remodelling in asthma. University of Southampton, Doctoral Thesis.

Record type: Thesis (Doctoral)

Abstract

The asthmatic airway demonstrates structural changes termed airway remodelling which include subepithelial collagen deposition and an increase in numbers of myofibroblasts in the mucosa. These changes may contribute to bronchial hyperresponsiveness and to decline in lung function in asthma.

The hypothesis was proposed that proteases, and in particular the plasminogen activating system, may mediate airway remodelling through the release of growth factors such as basic fibroblast growth factor (bFGF) and transforming growth factor-beta (TGF-β) from their binding to the extracellular matrix. The ability of bronchoalveolar lavage fluid (BALF) from asthmatic and non asthmatic subjects to stimulate proliferation in vitro of a transformed human fetal lung fibroblast cell line, MRC-5, was studied by measuring 3H-thymidine uptake.

Use of blocking antibodies and antiproteases demonstrated significant inhibition of BALF-induced fibroblast DNA synthesis (BIDS) by anti-bFGF, by a protease inhibitor cocktail and by the specific plasmin inhibitor, α2-antiplasmin. Plasmin concentrations of BALF correlated with BIDS. Plasmin was shown to stimulate marked proliferation of fibroblasts, an effect that was profoundly inhibited by anti-bFGF. Measurement of cell supernatant concentrations demonstrated rapid release of bFGF from fibroblasts exposed to plasmin. Immunofluorescent confocal microscopy demonstrated plasmin-induced loss of bFGF staining from fibroblasts in vitro. These observations suggest that plasmin is an important fibroproliferative agent in BALF mediating its activity through autocrine release of bFGF.

BIDS within an asthmatic group correlated significantly with bronchial hyperresponsiveness and BALF from steroid-naïve asthmatic subjects with marked bronchial hyperresponsiveness stimulated significantly greater BIDS than that from non-asthmatic subjects. BIDS also correlated with plasmin, bFGF and TGF-β levels in the BALF. Six weeks treatment with inhaled budesonide, nedocromil or placebo led to significant reductions in BIDS and plasmin concentrations only in the inhaled corticosteroid group and bFGF concentrations fell following treatment with budesonide, a change that was significantly different from that due to placebo.

Text
909961.pdf - Version of Record
Available under License University of Southampton Thesis Licence.
Download (13MB)

More information

Published date: 2003

Identifiers

Local EPrints ID: 465086
URI: http://eprints.soton.ac.uk/id/eprint/465086
PURE UUID: d9a55283-a377-4bdc-b4c8-bd795e680547

Catalogue record

Date deposited: 05 Jul 2022 00:22
Last modified: 16 Mar 2024 19:56

Export record

Contributors

Author: William David McConnell

Download statistics

Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.

View more statistics

Atom RSS 1.0 RSS 2.0

Contact ePrints Soton: eprints@soton.ac.uk

ePrints Soton supports OAI 2.0 with a base URL of http://eprints.soton.ac.uk/cgi/oai2

This repository has been built using EPrints software, developed at the University of Southampton, but available to everyone to use.

We use cookies to ensure that we give you the best experience on our website. If you continue without changing your settings, we will assume that you are happy to receive cookies on the University of Southampton website.

×